News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
NCI Division of Cancer Biology – Mark Hatley’s research in pediatric rhabdomyosarcoma
Photo taken from NCI Division of Cancer Biology/X
Jul 27, 2024, 09:14

NCI Division of Cancer Biology – Mark Hatley’s research in pediatric rhabdomyosarcoma

NCI Division of Cancer Biology shared on X:

“Dr. Mark Hatley from St. Jude Research is studying mediators of arrested cell differentiation and tumor growth in pediatric rhabdomyosarcoma.”

Read further.
Source: NCI Division of Cancer Biology/X

cancer Mark Hatley NCI Division of Cancer Biology OncoDaily Oncology rhabdomyosarcoma St. Jude Research
Special Coverage
Blog
Jan 6, 2025, 11:39
Sami (Papacek) Mansfield: The next cohort of the My Lifestyle Shift program
Blog
Jan 6, 2025, 11:35
Biagio Ricciuti: TROPICS-03 trial - Sacituzumab Govitecan in 2L extensive stage SCLC
Insight
Jan 6, 2025, 11:11
Akhil Santhosh: Switching 5 FU for docetaxel in the Tp-EXTREME trial
Science
Jan 6, 2025, 11:03
Myeloma Paper of the Day, January 6th, suggested by Robert Orlowski
Blog
Jan 6, 2025, 10:47
Tata Mayaah Eveline: Humanity at Heart International stands in solidarity with all those impacted by cervical cancer
Blog
Jan 6, 2025, 10:45
Megan-Claire Chase: Warrior Megsie… the SUPERHERO
Science
Jan 6, 2025, 10:42
Malte Roerden: How different immune evasion mechanisms interfere with immunoediting of evolving tumors
Blog
Jan 6, 2025, 10:41
Roupen Odabashian: The second lesson in my series on using AI to enhance learning
Blog
Jan 6, 2025, 10:39
Sachin H. Jain: In 2025, I urge you to start seeing things clearly
Positive
Jan 6, 2025, 10:36
As we begin 2025, we express our deepest gratitude to all of our supporters - The Max Foundation
Insight
Jan 6, 2025, 10:31
Immunosuppression in the Lung, New Mathematical Models and More - AACR
Insight
Jan 6, 2025, 10:15
Nelson Dusetti: New therapeutic avenues for new therapeutic avenues for improving PDAC treatment